Literature DB >> 27754530

Monitoring delays in diagnosis of pulmonary tuberculosis in eight cities in Colombia.

David A Rodríguez, Kristien Verdonck, Karen Bissell, Juan José Victoria, Mohammed Khogali, Diana Marín, Ernesto Moreno.   

Abstract

Objective To measure time between onset of tuberculosis (TB) symptoms and start of treatment, and to identify factors associated with delay in eight Colombian cities. Methods Operational research with a retrospective analytical cohort design was conducted in 2014 using routinely collected data about new smear-positive pulmonary TB patients from eight cities in Colombia (Barranquilla, Bogotá, Bucaramanga, Cali, Cúcuta, Medellín, Pereira, and Villavicencio). Date of symptom onset was sourced from TB surveillance databases. Data on all other variables came from National TB Program (NTP) registers. Results There were 2 545 new cases of smear-positive pulmonary TB, but a plausible date of symptom onset was available for only 1 456 (57%). Median number of days between symptom onset and treatment start was 51 days (interquartile range: 27-101). A total of 72% of patients had a delay (> 30 days between symptom onset and treatment start), and 28% had a 3+ bacillary load at diagnosis. Based on multiple logistic regression, three factors were significantly associated with delay: being uninsured (odds ratio (OR): 1.30; 95% confidence interval (CI): 1.01-1.68) and having an unknown HIV status (OR: 1.81; CI: 1.04-3.17), which increased risk, and coming from a neighborhood with NTP-employed community health workers, which decreased risk (OR: 0.56; CI: 0.34-0.90). Conclusions Delays still prevent timely TB diagnosis and treatment in Colombia. As the country aims for TB elimination, delays must be reduced, especially in cities and vulnerable neighborhoods, to stop community transmission. The NTP should focus not only on the number of cases detected but also on how long it takes to detect them. To monitor interventions designed to reduce delays, additional dates in the process should be recorded routinely. In addition, reliability and completeness of data are crucial for monitoring.

Entities:  

Mesh:

Year:  2016        PMID: 27754530

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  7 in total

1.  Prevalence of tuberculosis infection in healthcare workers of the public hospital network in Medellín, Colombia: a Bayesian approach.

Authors:  J Ochoa; A L León; I C Ramírez; C M Lopera; E Bernal; M P Arbeláez
Journal:  Epidemiol Infect       Date:  2017-01-09       Impact factor: 4.434

2.  Delay from symptom onset to treatment start among tuberculosis patients in England, 2012-2015.

Authors:  M G Loutet; C Sinclair; N Whitehead; C Cosgrove; M K Lalor; H L Thomas
Journal:  Epidemiol Infect       Date:  2018-06-20       Impact factor: 4.434

3.  Delays in diagnosing pulmonary tuberculosis within a context of medium incidence, Medellín, Colombia, 2017: an operational research.

Authors:  Iader Rodríguez-Márquez; Fernando Montes; Luz D Upegui; Nilton Montoya; Nelly E Vargas; Abelardo Rojas; Gloria C Valencia; Claudia M Álvarez; Leonardo Uribe; Jesús Ochoa
Journal:  BMC Public Health       Date:  2020-05-24       Impact factor: 3.295

4.  Patient Delay in Initiating Tuberculosis Treatment and Associated Factors in Oromia Special Zone, Amhara Region.

Authors:  Muhammed Abdu; Awraris Balchut; Eshetu Girma; Wondwosen Mebratu
Journal:  Pulm Med       Date:  2020-06-11

5.  Factors associated with delays in pulmonary tuberculosis diagnosis and treatment initiation in Cali, Colombia.

Authors:  Cindy Córdoba; Lucy Luna; Diana M Triana; Freddy Perez; Lucelly López
Journal:  Rev Panam Salud Publica       Date:  2019-03-15

6.  Total, Patient and System Diagnostic Delays for Pulmonary Bacilliferous Tuberculosis in the Six Diagnostic and Treatment Centers in the Five Health Districts of the Central Region, Burkina Faso, 2018.

Authors:  Pauline Kiswendsida Yanogo; Clarisse Balima; Nicolas Meda
Journal:  J Epidemiol Glob Health       Date:  2022-01-03

7.  Factors affecting the tuberculosis program coverage at the first level of care in Honduras

Authors:  Briana Beltrán; Dione Benjumea-Bedoya; Jackeline Alger
Journal:  Biomedica       Date:  2022-06-01       Impact factor: 1.173

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.